ReviewJournal of general internal medicine2020
Medication to Manage Abortion and Miscarriage.
Review in Journal of general internal medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 41 citations in OpenAlex.
- Understanding women's physical and emotional experiences following medication abortion in china: a qualitative study using the writing express method.BMC women's health · 2025Article
- The Origins and Proliferation of Unfounded Comparisons Regarding the Safety of Mifepristone.Biotech (Basel (Switzerland)) · 2025Article
- [Clinical aspects of the preparation, performance, and follow-up of a first trimester abortion].Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz · 2025Review
- High-risk factors for massive haemorrhage in medical abortion patients with missed miscarriage.BMC pregnancy and childbirth · 2024Article
- Medical management of first trimester missed miscarriages - A cross-sectional study.Pakistan journal of medical sciences · 2024Article
- Structural basis of prostaglandin efflux by MRP4.Nature structural & molecular biology · 2024Article
- Delays in Obtaining Abortion and Miscarriage Care Among Pregnant Persons in New York State During the COVID-19 Pandemic: The CAP Study.Women's health reports (New Rochelle, N.Y.) · 2024Article
- Review
- Update on the Role of Glucocorticoid Signaling in Osteoblasts and Bone Marrow Adipocytes During Aging.Current osteoporosis reports · 2023Review
- "Out of This World": Norwegian Women's Experiences of Medical Abortion Pain.Journal of multidisciplinary healthcare · 2023Article
- Managing Undesired Pregnancy After Dobbs.Journal of general internal medicine · 2022Article
- Mifepristone Increases Life Span in FemaleFrontiers in aging · 2022Article
- Making Medication Abortion a Part of Internal Medicine.Journal of general internal medicine · 2021Article
- Medication for Abortion and Miscarriage in Primary Care: Important and Possible for General Internists.Journal of general internal medicine · 2020Article
Corrections and comments
- Commented on by
Authors and funding
4 authors at 4 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Abortion and miscarriage are common, affecting millions of US women each year. By age 45, one in four women in the USA will have had an abortion, and at least as many will have had a miscarriage. Most individuals seeking abortion services do so before 10 weeks' gestation when medication abortions are a safe and effective option, using a regimen of oral mifepristone followed by misoprostol tablets. When a pregnancy is non-viable before 13 weeks' gestation, it is referred to as an early pregnancy loss or miscarriage and can be managed using the same mifepristone and misoprostol regimen. Given their safety and efficacy, mifepristone and misoprostol can be offered in ambulatory settings without special equipment or on-site emergency services. As more patients find it difficult to access clinical care when faced with an undesired pregnancy or a miscarriage, it is important for general internists and primary care providers to become familiar with how to use medications to manage these common conditions. We summarize the most recent evidence regarding the use of mifepristone with misoprostol for early abortion and miscarriage. We discuss clinical considerations and resources for integrating mifepristone and misoprostol into clinical practice. By learning to prescribe mifepristone and misoprostol, clinicians can expand access to time-sensitive health services for vulnerable populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.